Singapore adopts an abstinence-based approach to address the drug situation. We adopt a zero-tolerance stance towards drugs and the approach entails the following:
Running preventive drug education programmes to raise awareness on the harms of drug abuse;
Using tough laws and effective enforcement to tackle the drug demand and supply;
Employing evidence-based rehabilitation approach to reduce the risk of relapse among drug abusers; and
Engaging families and communities to be part of the anti-drug efforts.
To find out more on Singapore’s anti-drug strategy, please visit
https://www.mha.gov.sg/docs/default-source/others/mha_drugbooklet.pdf
The Biopsychosocial Model is a multidisciplinary model that draws focus to the 3 areas of a person’s life and how they interact. There are multiple factors that may draw a person to drug abuse and these can be classified under the Bio, Psycho and Social aspects of the person’s life.
SANA applies this model in conjunction with the Risk Needs and Responsivity Principle to help SANA case workers zoom into factors that affect the recovery of an ex-drug addict, either as areas to prioritize or areas to cover when discussing Relapse Prevention Plans.
When a client is referred to SANA for CMS, the case worker will begin by engaging client in the institution to conduct our intake and rapport building sessions. Home visits to client families (where available) will be conducted during this period as well.
In the Community Programming phase, case workers will follow up with clients monthly and their families quarterly. Case workers will work with clients on maintaining their abstinence and building relapse prevention strategies based on their presenting issues.
Post programme, case workers will link clients up with our Step-Up Centre if they are agreeable. The Centre offers various services such as support groups, financial assistance, job search and also para-counsellors to meet them should they require.
Chat with one of our counsellors through the free, anonymous and confidential live chat now!
Select Category
Managed by Ministry of Home Affairs – Central Narcotics Bureau
The dataset gives the number of drug abusers with a breakdown by various demographic factors such as age, gender, ethnic group and types of drugs abused.
Notes: The 2019 statistics are confirmed.
Classification of drug type is based on primary drug of abuse.
Buprenorphine was listed as a controlled drug under the Misuse of Drugs Act in Aug 2006.
NPS refers to those listed under 1st Schedule of the Misuse of Drugs Act wef 1 May 2014, as well as BZP, Mephedrone and TFMPP.
For more details on the Drug and Inhalant Situation, please refer to https://www.cnb.gov.sg/
Managed by Ministry of Home Affairs – Central Narcotics Bureau
The dataset gives the number of drug abusers with a breakdown by various demographic factors such as age, gender, ethnic group and types of drugs abused.
Notes: The 2019 statistics are confirmed.
Classification of drug type is based on primary drug of abuse.
Buprenorphine was listed as a controlled drug under the Misuse of Drugs Act in Aug 2006.
NPS refers to those listed under 1st Schedule of the Misuse of Drugs Act wef 1 May 2014, as well as BZP, Mephedrone and TFMPP.
For more details on the Drug and Inhalant Situation, please refer to https://www.cnb.gov.sg/
Managed by Ministry of Home Affairs – Central Narcotics Bureau
The dataset gives the number of drug abusers with a breakdown by various demographic factors such as age, gender, ethnic group and types of drugs abused.
Notes: The 2019 statistics are confirmed.
Classification of drug type is based on primary drug of abuse.
Buprenorphine was listed as a controlled drug under the Misuse of Drugs Act in Aug 2006.
NPS refers to those listed under 1st Schedule of the Misuse of Drugs Act wef 1 May 2014, as well as BZP, Mephedrone and TFMPP.
For more details on the Drug and Inhalant Situation, please refer to https://www.cnb.gov.sg/
Managed by Ministry of Home Affairs – Central Narcotics Bureau
The dataset gives the number of drug abusers with a breakdown by various demographic factors such as age, gender, ethnic group and types of drugs abused.
Notes: The 2019 statistics are confirmed.
Classification of drug type is based on primary drug of abuse.
Buprenorphine was listed as a controlled drug under the Misuse of Drugs Act in Aug 2006.
NPS refers to those listed under 1st Schedule of the Misuse of Drugs Act wef 1 May 2014, as well as BZP, Mephedrone and TFMPP.
For more details on the Drug and Inhalant Situation, please refer to https://www.cnb.gov.sg/
Managed by Ministry of Home Affairs – Central Narcotics Bureau
The dataset gives the number of drug abusers with a breakdown by various demographic factors such as age, gender, ethnic group and types of drugs abused.
Notes: The 2019 statistics are confirmed.
Classification of drug type is based on primary drug of abuse.
Buprenorphine was listed as a controlled drug under the Misuse of Drugs Act in Aug 2006.
NPS refers to those listed under 1st Schedule of the Misuse of Drugs Act wef 1 May 2014, as well as BZP, Mephedrone and TFMPP.
For more details on the Drug and Inhalant Situation, please refer to https://www.cnb.gov.sg/
SINGAPORE ANTI-NARCOTICS ASSOCIATION
The fight against drug abuse starts with building self-worth, and enabling self-determination.
Social
© Singapore Anti-Narcotics Association. All rights reserved
Enter your email address to follow the latest news and events through our e-alerts.
